The future of Advanced Therapies


The Advanced Therapies Congress is Europe’s largest cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.

 

New for 2025: Patient Delivery Track

In this track experts will discuss strategies for working with patient groups, nursing perspectives and the use of real-world evidence, all with the common goal of ensuring those most in need have access to life saving cell and gene therapies.

 


With 10 tracks of content, the agenda covers everything from manufacturing, supply chain & logistics, pricing & market access, to developments in key therapeutic areas; cell therapy, gene therapy, gene modified cell therapy, immunotherapy, and much more.

 

Stay up-to-date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.

Advanced Therapies 2025 will feature

 

To unite advanced therapies leaders from across the world, to give insight and to promote collaboration to accelerate the development & commercialisation of next generation medicines, bring them to market and help change patient lives.


For the past 20 years, the Advanced Therapies Congress has evolved and grown into the leading cell and gene conference and exhibition globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities.

300 expert speakers
10 tracks
100 sponsors
150 start-ups & 100 posters
3000+ attendees
Smart AI assisted networking
One to one meetings
More: Roundtables, panels, workshops, opportunities to meet face to face

 

London & The UK

London has a long history as a centre for advancement in medicine and biology and today, together with Oxford and Cambridge, forms the ‘Golden Triangle’, a global hub for life sciences. Across the UK, there are 6,300 life sciences businesses, generating an £80.7bn turnover, and employing more than 256,000 people.

There are over 130 advanced therapies companies in the UK, with 60% residing in the greater southeast of England, including university spinouts such as Orchard Therapeutics, Autolus, Cell Medica, GammaDelta Therapeutics and Astellas.

London benefits from excellence and expertise within academia, industry and the National Health Service (NHS) and is a dynamic hub for spinouts, scaling companies and investment.

Home to world-leading universities, hospitals and an expansive patient pool, the region is a growing engine room for translational and experimental medicine, with several National Institute for Health Research (NIHR) Biomedical Research Centres sitting between academia and the NHS and three of England’s Academic Health Sciences Centres.

 

 

We’ve been sparking ideas, innovations and relationships that transform business for over 30 years. Using our global footprint, we bring innovators, disrupters and change agents together. Discussing and demonstrating the technology, strategies and personalities that are changing the way the world does business.


Our world leading events bring scale, knowledge, and gravitas to promote innovation and technology that change people’s lives. Whether it is solar and renewables in Africa, education technology in Australia, payments and e-commerce in Asia, railways in the Middle East, orphan drugs in the Americas, or aviation in Europe, our events make a difference. We are creative, organic, and customer focused, curating content for the specific industry and location of each event. Whether you’re looking to make new connections, introduce product or inspire change in your industry, we invite you to join us as agitators of change.


www.terrapinn.com

 


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Ila Dickinson
ila.dickinson@terrapinn.com
+44 207 092 1150